-
Top 4 NYSE Stocks In The Medical Laboratories & Research Industry With The Highest ROE
Tuesday, November 4, 2014 - 5:22am | 130Below are the top medical laboratories & research stocks on the NYSE in terms of return on equity. The trailing-twelve-month return on equity at Laboratory Corp. of America Holdings (NYSE: LH) is 19.90%. Laboratory Corp's EPS for the same period is $5.96. The trailing-twelve-month return on...
-
Benzinga's M&A Chatter for Monday November 3, 2014
Monday, November 3, 2014 - 7:26pm | 487The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday October 31 through Sunday November 2, 2014: Aetna to Acquire Bswift for $400M The Deal:Aetna (NYSE: AET) announced Monday it will acquire privately-held bswift, for approximately $400 million. Bswift...
-
Mid-Afternoon Market Update: Covance Surges After LabCorp Deal; American Realty Capital Shares Slide
Monday, November 3, 2014 - 3:11pm | 686Toward the end of trading Monday, the Dow traded up 0.03 percent to 17,395.17 while the NASDAQ surged 0.33 percent to 4,646.13. The S&P also rose, gaining 0.18 percent to 2,021.72. Leading and Lagging Sectors Technology shares climbed by 0.49 percent in today’s trading. Top gainers...
-
Benzinga's Volume Movers
Monday, November 3, 2014 - 10:21am | 168Sapient (NASDAQ: SAPE) shares climbed 41.97% to $24.59. The volume of Sapient shares traded was 10298% higher than normal. Publicis (OTC: PUBGY) announced its plans to buy Sapient for $3.7 billion in cash. Covance (NYSE: CVD) shares moved up 25.24% to $100.07. The volume of Covance traded was 2767...
-
Morning Market Movers
Monday, November 3, 2014 - 9:38am | 229Sapient (NASDAQ: SAPE) shares climbed 42.03% to $24.60 after Publicis Groupe SA (OTC: PUBGY) agreed to acquire Sapient for $3.7 billion in cash. Geron (NASDAQ: GERN) shares rose 27.80% to $2.85 after the company announced the removal of full clinical hold on Imetelstat IND. Covance (NYSE: CVD)...
-
Benzinga's Top #PreMarket Gainers
Monday, November 3, 2014 - 8:09am | 139Sapient (NASDAQ: SAPE) shares jumped 42.09% to $24.61 after Publicis Groupe SA (OTC: PUBGY) agreed to acquire Sapient for $3.7 billion in cash. Geron (NASDAQ: GERN) shares gained 31.39% to $2.93 after the company announced the removal of full clinical hold on Imetelstat IND. Covance (NYSE: CVD)...
-
UPDATE: Covance Posts In-Line Q3 Earnings
Monday, November 3, 2014 - 8:09am | 262Covance (NYSE: CVD) reported in-line earnings for the third quarter. Laboratory Corp of America Holdings (NYSE: LH) announced its plans to acquire Covance for around $6.1 billion in cash and stock. The Princeton, New Jersey-based company reported quarterly earnings of $66 million, or $1.16 per...
-
US Stock Futures Drop Ahead Of Economic Data
Monday, November 3, 2014 - 7:28am | 457Pre-open movers US stock futures traded lower in early pre-market trade. Data on motor vehicle sales for October will be released today. The Markit PMI manufacturing index for October will be released at 9:45 a.m. ET, while the ISM manufacturing composite index for October and construction spending...
-
LabCorp To Acquire Covance For $5.6B
Monday, November 3, 2014 - 6:03am | 1314Laboratory Corporation of America^® Holdings (LabCorp^®) (NYSE: LH) and Covance Inc. (NYSE: CVD) today announced that they have entered into a definitive agreement under which LabCorp will acquire Covance for cash and LabCorp shares currently valued at $105.12 per Covance share, or an equity value...
-
LabCorp Introduces HIV-1 Next Generation Sequencing Assay To Support Drug Regimen Changes In HIV Suppressed Patients
Monday, October 20, 2014 - 7:50am | 394Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) and Monogram Biosciences, Inc., part of the LabCorp Specialty Testing Group, today announced the launch of HIV GenoSure ArchiveSM, the first laboratory test to help optimize antiretroviral (ARV) drug regimens in virally suppressed...
-
Top 4 Small-Cap Stocks In The Home Health Care Industry With The Highest Profit Margin
Wednesday, October 8, 2014 - 4:12am | 120Below are the top small-cap home health care stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Chemed (NYSE: CHE) is 6.10%. Chemed's PEG ratio is 1.42. The trailing-twelve-month profit margin at LHC Group (NASDAQ: LHCG) is 3.00%. LHC Group's EPS...
-
Benzinga's M&A Chatter for Thursday September 25, 2014
Thursday, September 25, 2014 - 6:44pm | 329The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday September 25, 2014: Labcorp to Acquire Liposcience for $5.25/Share in Cash The Deal:Laboratory Corporation of America Holdings (NYSE: LH) and LipoScience, Inc. (NASDAQ: LPDX) announced Wednesday, a...
-
Top 4 Stocks In The Home Health Care Industry With The Highest ROE
Friday, September 5, 2014 - 3:52am | 126Below are the top home health care stocks on the NYSE and the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Gentiva Health Services (NASDAQ: GTIV) is 182.40%. Gentiva Health's revenue for the same period is $1.88 billion. The trailing-twelve-month return on...
-
Top 4 Stocks In The Home Health Care Industry With The Highest Profit Margin
Wednesday, August 27, 2014 - 3:57am | 119Below are the top home health care stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Chemed (NYSE: CHE) is 6.10%. Chemed's PEG ratio is 1.46. The trailing-twelve-month profit margin at LHC Group (NASDAQ: LHCG) is 3.00%. LHC Group's ROE for the...
-
LabCorp Announces The Availability Of InformaSeqSM Non-Invasive Prenatal Test
Tuesday, August 19, 2014 - 7:51am | 345Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the availability of the informaSeq Prenatal Test. The informaSeq Prenatal Test is an advanced, non-invasive, next-generation prenatal screening assay that can assess risk for multiple fetal chromosomal aneuploidies,...